Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Barclays downgraded athenahealth, Inc (NASDAQ: ATHN) from Equal-weight to Underweight. The price target for AthenaHealth has been lowered from $140 to $110. AthenaHealth shares closed at $162.98 on Monday.

Analysts at Brean Capital downgraded Osiris Therapeutics, Inc. (NASDAQ: OSIR) from Hold to Sell. The price target for Osiris Therapeutics is set to $8. Osiris Therapeutics shares closed at $13.98 on Monday.

Wedbush downgraded Polaris Industries Inc. (NYSE: PII) from Outperform to Neutral. The price target for Polaris Industries has been lowered from $156 to $117. Polaris Industries shares closed at $105.49 on Monday.

RBC Capital downgraded Urban Outfitters, Inc. (NASDAQ: URBN) from Outperform to Sector Perform. The price target for Urban Outfitters has been lowered from $32 to $23. Urban Outfitters shares closed at $22.67 on Monday.

Analysts at Sterne Agee CRT downgraded Five Below Inc (NASDAQ: FIVE) from Buy to Neutral. The price target for Five Below has been lowered to $30. Five Below shares closed at $28.49 on Monday.

BMO Capital downgraded Kindred Biosciences Inc (NASDAQ: KIN) from Outperform to Market Perform. The price target for Kindred Biosciences has been lowered from $14 to $5. Kindred Biosciences shares closed at $4.73 on Monday.

Analysts at Oppenheimer downgraded Hess Corp. (NYSE: HES) from Outperform to Perform. Hess shares closed at $61.84 on Monday.

Atlantic Equities downgraded W W Grainger Inc (NYSE: GWW) from Neutral to Underweight. The price target for W W Grainger has been lowered from $220 to $183. W W Grainger shares closed at $198.28 on Monday.

Analysts at KeyBanc downgraded Airgas, Inc. (NYSE: ARG) from Overweight to Sector Weight. Airgas shares closed at $106.18 on Monday.

Analysts at Goldman Sachs downgraded Clovis Oncology Inc (NASDAQ: CLVS) from Buy to Neutral. The price target for Clovis Oncology has been lowered from $123 to $23. Clovis Oncology shares closed at $30.24 on Monday.

Latest Ratings for ATHN

DateFirmActionFromTo
Dec 2018MaintainsEqual-WeightEqual-Weight
Nov 2018DowngradesOutperformMarket Perform
Nov 2018MaintainsHoldHold

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ATHN + ARG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
HELEMaintains160.0
JWNMaintains32.0
DYMaintains64.0
PSTGMaintains18.0
TJXMaintains56.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Piper Jaffray Thinks This Peanut Allergy Biotech Could Double After Meeting Management

TJX Tops Q3 Estimates, Shares Gain